About the Authors

About the Authors Sönke Albers is Professor of Marketing and Innovation and Dean of Research at Kühne Logistics University in Hamburg, Germany. Up to 2010, he served more than 20 years as Professor of Innovation, New Media, and Marketing at Christian- Albrechts- University at Kiel, Germany. He holds a Ph.D. in Operations Research from University of Hamburg. He is Fellow of the European Marketing Academy and served as President of the German Academic Association for Business Research which comprises nearly all 1800 business professors in Germany, Austria, and Switzerland. His research interests are lying in the areas of marketing planning and sales management. He is author of about 150 articles in international and German journals such as Marketing Science, Journal of Marketing Research, and International Journal of Research in Marketing and published over 10 books. He is editor-in-chief and department editor Marketing of BuR—Business Research and on the editorial boards of the International Journal of Research in Marketing and other journals. He works with pharmaceutical companies on deployment issues and budgeting. For his work with Bayer he won the ISMS-MSI Practice Prize Competition in 2010. Reinhard Angelmar (“Vaccine Marketing”) is Emeritus Professor of Marketing and the Salmon and Rameau Fellow of Healthcare Management, Emeritus, at INSEAD, Fontainebleau. He received his M.B.A. and Ph.D. from Northwestern University. His articles have appeared in the Journal of Marketing Research , Journal of Industrial Economics , Journal of Marketing , and others. With a long- standing interest in pharmaceuticals, he has worked with companies such as Abbott, Amgen, AstraZeneca, Bristol-Myers Squibb, Johnson & Johnson, Novartis, Novo Nordisk, Pfi zer, Roche, Sanofi Pasteur, and Takeda. He has also carried out assign- ments as an expert in litigations between pharmaceutical companies. Ulrich A.K. Betz is Director, Head of the department Innovation and Entrepreneurship Incubator at Merck Serono, a division of Merck KGaA. In this function he is responsible for global innovation management at Merck Serono. For example, he designed and implemented a Merck wide innovation initiative with global idea sourcing and enablement in an entrepreneurial context and an M. Ding et al. (eds.), Innovation and Marketing in the Pharmaceutical Industry, 737 International Series in Quantitative Marketing 20, DOI 10.1007/978-1-4614-7801-0, © Springer Science+Business Media New York 2014 738 About the Authors innovation incubator under direct board governance, initiated the Merck Serono Innovation Cup and started a comprehensive open innovation and crowd sourcing platform. Before taking over this responsibility he was leading the department Strategic Innovation and Research Portfolio Management in Merck Serono Discovery Research. In this function he was responsible for portfolio management, alliance management, and scouting and business development in discovery and was coordi- nating various senior management committees. Dr. Betz joined Merck in June 2005 as the Global Operations Manager for the Executive VP Preclinical R&D. In this function he was responsible for the global annual budgeting at Preclinical R&D Merck Pharma Ethicals. During post-merger integration he coordinated the design of the new drug discovery process and mile- stone criteria after the acquisition of Serono. Prior to joining Merck, he worked 7 years for Bayer AG in various scientifi c and managerial positions in Pharma Research, including as the strategic assistant of the global Head of Pharma R&D at Bayer HealthCare. He designed and implemented the Pharma Research Europe Science & Technology Award and closed biotech part- nering deals to identify new drug targets. One of the drug discovery projects which Dr. Betz has initiated in the area of anti-infectives has moved forward to clinical phase III. Another one is in clinical phase II. Dr. Betz received his Ph.D. in functional genomics and immunology from the University of Cologne and his diploma in biochemistry and physiological chemistry from the University of Tübingen. Dr. Betz is author and coauthor of more than 70 publications (e.g., Cell, Nature Medicine) and patents. He is married and has three children. Tulikaa Bhatia was an assistant professor at Rutgers University at the time of writing this book chapter. She has since then joined the industry and is working on putting her ideas into practice. Dr. Bhatia has more than 10 years of pharmaceutical experience, both in industry and academia, on core business issues to identify and capture top-line growth opportunities. She is the author of several publications in top peer-reviewed journals such as Journal of Marketing Research and the International Journal of Research in Marketing . Dr. Bhatia’s areas of expertise are physician decision making, identifying and measuring peer-to-peer network infl u- ence, and sales promotion effectiveness. Dr. Bhatia received her Doctorate in Marketing from Kellogg School of Management, Northwestern University. She has a degree in Computer engineering from Birla Institute of Technology, Mesra, and an M.B.A. from Indian Institute of Management Calcutta. Lauren G. Block is the Lippert Professor of Marketing at the Zicklin School of Business, Baruch College. She received her Ph.D. in marketing from Columbia University and her M.B.A. from Emory University. Prior to Baruch, Dr. Block was on the faculty of New York University’s Stern School of Business. Dr. Block’s work is primarily in areas of health-persuasion, health-goal achievement, and food well- being. Her research examines how integrated communications can be most effec- tively utilized to change consumer health-related attitudes and behavior. Current research focuses on how best to use marketing tools, like food labeling and product About the Authors 739 packaging, to facilitate healthier lifestyle decisions. Her work in these areas has been published in our fi eld’s major journals, such as Journal of Public Policy & Marketing , Journal of Marketing Research , Journal of Consumer Research , Journal of Consumer Psychology , and American Journal of Public Health . Dr. Block is a current Associate Editor for the Journal of Public Policy & Marketing , and the Journal of Consumer Research . She also serves on the Ad Council Research Committee. Dr. Block teaches doctoral level, M.B.A., and undergraduate courses in Marketing Management and Consumer Behavior. She has been the Marketing core faculty in Baruch’s distinguished Baruch/Mt. Sinai Graduate M.B.A. program in Health Care Administration since 2003. She was the recipient of the 2008 Richard W. Pollay Prize for Intellectual Excellence of Research on Marketing in the Public Interest. Nuno Camacho is Assistant Professor of Marketing at the Erasmus School of Economics, Erasmus University Rotterdam (the Netherlands). His research interests include behavioral modeling (i.e., building econometric models to study individual and joint consumer decision processes) and behavioral economics applied to marketing. In terms of substantive focus, he has been working on topics in pharmaceutical and health marketing and in several projects in the life sciences industry. He has worked on topics related to the adoption of new therapies (e.g., modeling the diffu- sion of AstraZeneca’s Symbicort in the Netherlands, and its competition with GlaxoSmithKline’s Seretide/Advair), patient adherence to doctors’ advice across 17 different countries and several therapeutic areas, and patients’ propensity to request drugs by brand name (also in different countries). He has also been involved—for instance, through case writing and preparation of case-based sessions—with managerial challenges faced by many companies within the life sciences industry (such as AstraZeneca, Bayer, Biocon, Elli Lilly, Genomic Health, Genzyme, Medicines Company, Merck Serono, Parexel, PatientsLikeMe, and Sanofi -Aventis). Tat Chan is an Associate Professor of Marketing at the Olin Business School, Washington University in St. Louis. He received a Ph.D. in Economics at Yale University in 2001. His research interests are in empirical modeling consumer choice and fi rm competition using econometric methodologies. He has conducted various research projects in the domain of pharmaceutical marketing, with topics on detailing, clinical trials, physician, and patient learning of the effectiveness and side effects of new drugs. Some of the research has been published in top journals such as Journal of Political Economy and Management Science. James G. Conley serves on the faculty of the Kellogg School of Management and the McCormick School of Engineering at Northwestern University. He is a faculty contributor in the Kellogg Center for Research in Technology & Innovation and serves as a Faculty Fellow at the Segal Design Institute. Beyond academia, he served as an appointed member on the USA Department of Commerce Trademark Public Advisory Committee and is a Charter Fellow of the National Academy of Inventors. His research investigates the strategic use of intangible assets and intellectual prop- erties to build and sustain competitive advantage. This research is informed by the 740 About the Authors practice of inventing and licensing his portfolio of patents that have been litigated and licensed to many fortune 500 companies in the USA, Europe, and Asia. He has served as a consultant to fi rms such as Caterpillar, Sony, Eisai Ltd., Amsted Industries, Honda Motors Ltd., Black & Decker, Microsoft, Intuit, Stihl

Load more